title: ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?
authors.affiliation: Department of Nephrology, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany.
authors.forename: J T
authors.initials: JT
authors.lastname: Kielstein
authors.forename: J C
authors.initials: JC
authors.lastname: Frölich
authors.forename: H
authors.initials: H
authors.lastname: Haller
authors.forename: D
authors.initials: D
authors.lastname: Fliser
mesh_terms: D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000502:physiology*; D001161:Arteriosclerosis / Q000209:etiology*; D004791:Enzyme Inhibitors / Q000378:metabolism; D006801:Humans; D007674:Kidney Diseases / Q000150:complications* / Q000503:physiopathology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*
chemical_list: D004791:Enzyme Inhibitors; C018524:N,N-dimethylarginine; D001120:Arginine; D019001:Nitric Oxide Synthase